As the importance of managing cancer diseases increases in the COVID-19 pandemic era, we analyzed the difference in the survival rate according to ACE2 expression levels in 31 cancers by using The Cancer Genome Atlas (TCGA) dataset. This evidence concerns the gene ACE2 and cancer.